These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10189 related items for PubMed ID: 10465578

  • 1. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
    Palomares T, Bilbao P, del Olmo M, Castro B, Calle Y, Alonso-Varona A.
    Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
    Palomares T, Alonso-Varona A, Alvarez A, Castro B, Calle Y, Bilbao P.
    Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
    [Abstract] [Full Text] [Related]

  • 3. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M, Alonso-Varona A, Castro B, Calle Y, Bilbao P, Palomares T.
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B, Keshelava N, Anderson CP, Reynolds CP.
    Cancer Res; 2003 Apr 01; 63(7):1520-6. PubMed ID: 12670899
    [Abstract] [Full Text] [Related]

  • 5. Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo.
    Révész L, Edgren MR, Wainson AA.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):403-6. PubMed ID: 8195041
    [Abstract] [Full Text] [Related]

  • 6. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Pigment Cell Res; 1997 Aug 15; 10(4):236-49. PubMed ID: 9263331
    [Abstract] [Full Text] [Related]

  • 7. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ.
    Cell Death Differ; 2002 Mar 15; 9(3):252-63. PubMed ID: 11859408
    [Abstract] [Full Text] [Related]

  • 8. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD, Raha GA, Springer DL, Meadows GG.
    Pigment Cell Res; 1991 Dec 15; 4(5-6):234-9. PubMed ID: 1823927
    [Abstract] [Full Text] [Related]

  • 9. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA, Lehman CM, Biaglow JE, Peck VM.
    Radiat Res; 1988 May 15; 114(2):215-24. PubMed ID: 3375425
    [Abstract] [Full Text] [Related]

  • 10. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM, Curry-McCoy TV, Todero SL, White RL, Kharbanda KK, Nanji AA, Osna NA.
    Alcohol Clin Exp Res; 2007 Jun 15; 31(6):1053-60. PubMed ID: 17428293
    [Abstract] [Full Text] [Related]

  • 11. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
    Prezioso JA, FitzGerald GB, Wick MM.
    J Invest Dermatol; 1992 Sep 15; 99(3):289-93. PubMed ID: 1512464
    [Abstract] [Full Text] [Related]

  • 12. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Sep 15; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 13. L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases.
    Bilbao P, del Olmo M, Alonso-Varona A, Castro B, Bilbao J, Palomares T.
    Melanoma Res; 2002 Feb 15; 12(1):17-26. PubMed ID: 11828254
    [Abstract] [Full Text] [Related]

  • 14. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
    Sancho P, Fernández C, Yuste VJ, Amrán D, Ramos AM, de Blas E, Susin SA, Aller P.
    Apoptosis; 2006 May 15; 11(5):673-86. PubMed ID: 16532269
    [Abstract] [Full Text] [Related]

  • 15. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ.
    Toxicology; 1994 Mar 11; 88(1-3):177-89. PubMed ID: 8160199
    [Abstract] [Full Text] [Related]

  • 16. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.
    Breast Cancer Res; 2008 Mar 11; 10(6):R104. PubMed ID: 19061505
    [Abstract] [Full Text] [Related]

  • 17. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW, Beyers KL.
    Br J Cancer; 1993 Dec 11; 68(6):1071-9. PubMed ID: 8260357
    [Abstract] [Full Text] [Related]

  • 18. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Chem Biol Interact; 1998 Apr 24; 111-112():277-305. PubMed ID: 9679561
    [Abstract] [Full Text] [Related]

  • 19. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC, Harris JW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 24; 12(7):1171-4. PubMed ID: 3744936
    [Abstract] [Full Text] [Related]

  • 20. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
    Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Viña J, Estrela JM.
    Biochem J; 1993 Jun 01; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 510.